Over a 10-year period, spending for Medicaid-enrolled patients with depression increased substantially but only minimal improvements in quality of care were observed, according to a report in the December issue of Archives of General Psychiatry, one of the JAMA/Archives journals. The study was carried out by Catherine A. Fullerton, M.D., M.P.H., of Harvard Medical School […]
Tag Archives | Pharmaceuticals
Early Interventions For Schizophrenia Look Promising, But Hard Evidence Remains Inconclusive
Schizophrenia is a chronic illness that most often comes on in late adolescence or young adulthood and can devastate patients’ lives. Many physicians and researchers believe that early intervention can increase the chances for recovery, reduce recurrences and even prevent the warning signs of psychosis from progressing to the actual disease. Yet, a systematic review […]
Placebo Effect Leads To Substantial Headache Recovery Rate
Headache is a very common complaint with over 90% of all persons experiencing a headache at some time in their lives. Headaches commonly are tension-type (TTH) or migraine. They have high socioeconomic impact and can disturb most daily activities. Treatments range from pharmacologic to behavioral interventions. In a study published online today in the Journal […]
Medical And Behavioral Treatments Show Promise To Reduce Autism-Related Behaviors
Some medical and behavioral treatments show promise for reducing certain behaviors in children with autism spectrum disorders (ASDs), but more research is needed to assess the potential benefits and harms, according to a new report funded by HHS’ Agency for Healthcare Research and Quality. The research results were published online in the journal Pediatrics. Check the […]
Naltrexone (Revia) Works Best In Specific Populations With Alcohol Dependence
Results from a new study suggest that one of the most prescribed medications for alcohol dependence may be more effective in some people. Preliminary results show that naltrexone (Revia), one of the only medications approved for treating people with alcohol abuse problems, may only be effective in women and those with a specific genetic variation. […]
Depolarizing The Debates About Pediatric Mental Health Diagnosis And Treatment
Decisions about whether and how to diagnose children with emotional and behavioral disturbances, and whether and how to treat them, are sometimes not clear-cut. When decisions lie within a “zone of ambiguity,” people who emphasize different value commitments can reach different but equally respectable conclusions. We need to tolerate these reasonable disagreements, according to a […]
Medication Education Key To Adherence For Patients With Diabetes
Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego say that medication education is a key factor in helping patients with diabetes better stick to their drug treatments plans. The study, currently online in the February issue of the journal Annals of Pharmacotherapy, points to the need for […]
Inconsistencies In Medication Black Box Warnings Need New Transparent Regulatory Rules
A new study highlights inconsistencies in black box warnings – medication-related safety warnings on a drug’s label – and argues for a more transparent and systematic approach to ensure these warnings are consistent across all drugs within a same category, and any additions to warnings (for example, on the back of a drug that details […]
Recent Comments